Pseudomonas aeruginosa, in spite of being a ubiquitous organism (as
it is found in soil, water, and humans), is also an opportunistic pathogen. In order
to maintain its diversity in the community, it produces various toxic proteins, known
as, bacteriocins. In the present study, pyocin SA189, which is a bacteriocin produced
by P. aeruginosa SA189 (isolated from a clinical sample) was
characterized. P. aeruginosa SA189, as identified by the
conventional and 16S rRNA gene amplification, produced pyocin SA189 of molecular
weight of 66 k Da. The pyocin showed antimicrobial activity against several
clinically relevant Gram-positive and Gram-negative bacteria and was substantially
stable for wide ranges of temperature and pH. Furthermore, the pyocin also retained
its biological activity upon treatment with metal ions, organic solvents, and various
proteolytic and lipolytic enzymes. The data from the growth kinetics indicated that
the maximum bacteriocin production occurred in the late log phase. Overall, our
results signify the potential of pyocin SA189 as a bio-control agent.